Corteva, Inc. filings document the reporting obligations of a NYSE-listed agriculture company with common stock registered under the Exchange Act. Form 8-K reports cover quarterly and annual operating results, furnished earnings releases, financial statement schedules, annual meeting voting results, executive officer changes, board matters, dividend-related disclosures, and strategic separation planning for its agriculture businesses.
The company's definitive proxy materials provide governance and compensation disclosures, including director elections, shareholder proposals, executive compensation tables, equity awards, board oversight, and stockholder voting matters. Corteva's filing record also identifies its capital structure, including common stock and preferred stock matters involving EIDP, Inc., a wholly owned subsidiary.
Corteva, Inc. Chief People Officer Jennifer L. Sloan reported direct holdings of 37,156.8686 common shares, including 26,431.1139 unvested restricted stock units and related dividend equivalent units. Her reported non-qualified stock options cover 4,396 shares at a $9.9400 exercise price and are fully vested and exercisable; 10,010 shares at $8.6700, of which 5,005 are vested and exercisable, with the remainder scheduled to vest on February 20, 2027; and 13,171 shares at $10.2800, of which 4,390 are vested and exercisable, with the remainder scheduled to vest in two equal installments on February 18, 2027, and February 18, 2028.
Corteva, Inc. Chief Legal Officer Karen G. Narwold reported direct holdings of 21,743 shares of Common Stock as of October 1, 2026. The accompanying footnote says the reported amount represents unvested restricted stock units and related dividend equivalent units.
On October 1, 2026, Corteva, Inc. Chief Technology Officer Reza J. Rasoulpour reported direct holdings of 20,091 common-stock units, representing unvested restricted stock units and related dividend equivalent units. He also reported non-qualified options covering 10,248, 13,340 and 11,854 common shares, exercisable at $9.94, $8.67 and $10.28, respectively. Some options are vested; remaining portions have stated vesting dates through February 18, 2028.
Corteva, Inc. reports Chief Integrated Ops Officer Ralph H. Ford III held 37,334 shares of common stock directly on October 1, 2026, including 35,776.26 unvested restricted stock units and related dividend equivalent units. His direct holdings also include three non-qualified stock option positions covering 5,858 shares at a $9.94 exercise price, 14,451 shares at $8.67, and 18,440 shares at $10.28. The options expire on February 28, 2033, February 20, 2034, and February 18, 2035, respectively.
Corteva, Inc. (CTVA) reports Chief Commercial Officer Brook M. Cunningham held 147,206 common shares as of October 1, 2026, including 126,021 unvested restricted stock units and related dividend equivalent units. Cunningham also held options covering 64,421 shares at a $9.94 exercise price, fully vested and exercisable; 76,696 shares at $8.67, with 51,130 vested and exercisable and the remainder vesting February 20, 2027; and 68,492 shares at $10.28, with 22,830 vested and exercisable and the remainder vesting in equal installments February 18, 2027 and February 18, 2028.
Corteva, Inc. Chief Financial Officer Jeffrey A. Rudolph reported a direct common-stock position of 90,759 shares as of October 1, 2026, including 90,577 unvested restricted stock units and related dividend equivalent units. He also reported non-qualified stock options covering 5,506 shares at an $8.67 exercise price, with an exercise date of February 20, 2027, and expiration on February 20, 2034. A second option position covers 9,659 shares at a $10.28 exercise price, expires February 18, 2035, and vests in equal installments on February 18, 2027 and February 18, 2028.
Corteva, Inc. reported equity-award adjustments for Brian Titus, VP, Corporate Finance & Accounting Officer, on October 1, 2026, in connection with the spin-off of its Seed business. The reported acquisitions were 14,772, 17,661 and 14,393 non-qualified options, with exercise prices of $9.94, $8.67 and $10.28, respectively.
The reported common-stock dispositions were 13,315 shares associated with converting pre-2026 performance stock units into restricted stock units and 11,083 shares representing the difference between the original and adjusted 2026 RSU award. The converted pre-2026 units remain subject to the original time-based vesting conditions.
Corteva, Inc. (CTVA) Chief Executive Officer Luther C. Kissam IV reported a disposition of 127,949 common shares on October 1, 2026, in connection with adjustment of the 2026 RSU award following the Spin-Off. The reported amount represents the difference between the original grant and the adjusted grant, calculated using the employer method defined under the EMA at an adjustment ratio of 6.2722; it includes DEUs associated with converted RSUs. Direct common-stock holdings following the transaction were 153,087 shares.
Corteva, Inc. (CTVA) reported that Jennifer Amy Johnson, its SVP and Chief Legal Officer, had 446 shares of common stock withheld on September 15, 2026 to pay tax liabilities arising from the vesting of previously granted restricted stock units. These shares were treated as a disposition by delivery to the company. After this tax-withholding event and including 79.5200 shares acquired through dividend reinvestment, Johnson now holds 16,849.2195 shares of Corteva common stock directly. No Rule 10b5-1 trading plan is reported for this transaction.
Corteva, Inc. (CTVA) reported that EVP and Chief Financial Officer David Paul Johnson had 8,517 shares of common stock withheld on September 16, 2026 to pay taxes due upon the vesting of previously granted restricted stock units, at a reported value of $81.01 per share. These shares were retained by the issuer rather than sold in the market, and no Rule 10b5-1 trading plan is reported for this transaction. Following these tax-withholding dispositions and including the acquisition of 314.8063 shares through dividend reinvestment, Johnson directly holds 73,625.7954 shares of Corteva common stock.